CN116064460B - 一种mmlv突变体及其应用 - Google Patents
一种mmlv突变体及其应用 Download PDFInfo
- Publication number
- CN116064460B CN116064460B CN202210916589.4A CN202210916589A CN116064460B CN 116064460 B CN116064460 B CN 116064460B CN 202210916589 A CN202210916589 A CN 202210916589A CN 116064460 B CN116064460 B CN 116064460B
- Authority
- CN
- China
- Prior art keywords
- mmlv
- mutant
- reverse transcriptase
- strand
- parent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000713869 Moloney murine leukemia virus Species 0.000 title claims abstract description 52
- 102100034343 Integrase Human genes 0.000 claims abstract description 23
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 16
- 238000010839 reverse transcription Methods 0.000 claims abstract description 14
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 10
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 10
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims description 18
- 238000006467 substitution reaction Methods 0.000 claims description 15
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims description 12
- 108010092160 Dactinomycin Proteins 0.000 claims description 9
- 229960000640 dactinomycin Drugs 0.000 claims description 9
- 102220585547 D site-binding protein_K52Q_mutation Human genes 0.000 claims description 7
- 102220527593 Prostaglandin E synthase_R70S_mutation Human genes 0.000 claims description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 6
- 102000040430 polynucleotide Human genes 0.000 claims description 6
- 239000002157 polynucleotide Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 238000012217 deletion Methods 0.000 abstract description 2
- 230000037430 deletion Effects 0.000 abstract description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 7
- 101150112014 Gapdh gene Proteins 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical group O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 3
- 101710203526 Integrase Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- PGSPUKDWUHBDKJ-UHFFFAOYSA-N 6,7-dihydro-3h-purin-2-amine Chemical compound C1NC(N)=NC2=C1NC=N2 PGSPUKDWUHBDKJ-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000006570 Euonymus japonicus Species 0.000 description 1
- 235000016796 Euonymus japonicus Nutrition 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
引物名称 | 序列(5'→3') | SEQ ID NO. |
GAPDH基因上游引物 | AGATCCCTCCAAAATCAAGTGG | 12 |
GAPDH基因下游引物 | GGCAGAGATGATGACCCTTTT | 13 |
重复1 | 重复2 | |
NR604对照(含ActD) | 0.99 | 0.98 |
NR604对照(不含ActD) | 0.90 | 0.90 |
突变体1(不含ActD) | 0.99 | 0.99 |
突变体2(不含ActD) | 0.99 | 0.98 |
突变体3(不含ActD) | 0.97 | 0.98 |
突变体4(不含ActD) | 0.98 | 0.98 |
突变体5(不含ActD) | 0.98 | 0.98 |
突变体6(不含ActD) | 0.99 | 0.99 |
突变体7(不含ActD) | 0.98 | 0.98 |
突变体8(不含ActD) | 0.97 | 0.98 |
突变体9(不含ActD) | 0.99 | 0.99 |
突变体10(不含ActD) | 0.99 | 0.99 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210916589.4A CN116064460B (zh) | 2022-08-01 | 2022-08-01 | 一种mmlv突变体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210916589.4A CN116064460B (zh) | 2022-08-01 | 2022-08-01 | 一种mmlv突变体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116064460A CN116064460A (zh) | 2023-05-05 |
CN116064460B true CN116064460B (zh) | 2023-09-26 |
Family
ID=86173739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210916589.4A Active CN116064460B (zh) | 2022-08-01 | 2022-08-01 | 一种mmlv突变体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116064460B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1422336A (zh) * | 2000-03-15 | 2003-06-04 | 茵维特罗根公司 | 高保真逆转录酶及其用途 |
CN107058258A (zh) * | 2008-04-10 | 2017-08-18 | 赛默飞世尔科技波罗的海Uvb公司 | 一种逆转录酶和编码其的多核苷酸 |
CN111647576A (zh) * | 2020-06-24 | 2020-09-11 | 南京诺唯赞生物科技股份有限公司 | 一种热稳定性逆转录酶突变体及其应用 |
-
2022
- 2022-08-01 CN CN202210916589.4A patent/CN116064460B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1422336A (zh) * | 2000-03-15 | 2003-06-04 | 茵维特罗根公司 | 高保真逆转录酶及其用途 |
CN107058258A (zh) * | 2008-04-10 | 2017-08-18 | 赛默飞世尔科技波罗的海Uvb公司 | 一种逆转录酶和编码其的多核苷酸 |
CN111647576A (zh) * | 2020-06-24 | 2020-09-11 | 南京诺唯赞生物科技股份有限公司 | 一种热稳定性逆转录酶突变体及其应用 |
Non-Patent Citations (1)
Title |
---|
Novel mutations in Moloney Murine Leukemia Virus reverse transcriptase increase thermostability through tighter binding to template-primer;Bahram Arezi, et al.;Nucleic Acids Res.;第37卷(第02期);473-481 * |
Also Published As
Publication number | Publication date |
---|---|
CN116064460A (zh) | 2023-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2914745B1 (en) | Barcoding nucleic acids | |
US8999677B1 (en) | Method for differentiation of polynucleotide strands | |
US8329887B2 (en) | Synthesis of tagged nucleic acids | |
CN105392901B (zh) | 连接酶-辅助的核酸环化和扩增 | |
EP3985122A1 (en) | Methods of producing amplified double stranded deoxyribonucleic acids and compositions and kits for use therein | |
JP2007502610A (ja) | 増幅法 | |
JP2006519621A (ja) | Dna重合プロセスにより生成される全ゲノムおよび全トランスクリプトームライブラリーの増幅および分析 | |
EP3330386A1 (en) | Preparation of adapter-ligated amplicons | |
US20210017580A1 (en) | Small rna detection method based on small rna primed xenosensor module amplification | |
JP2022516446A (ja) | 相補的dnaを調製するための方法およびキット | |
WO2023098492A1 (zh) | 测序文库构建方法及应用 | |
US20220017954A1 (en) | Methods for Preparing CDNA Samples for RNA Sequencing, and CDNA Samples and Uses Thereof | |
JP6876785B2 (ja) | 単分子配列決定のための一本鎖環状dnaライブラリーを生成するための方法 | |
EP3485034B1 (en) | System and method for transposase-mediated amplicon sequencing | |
CN116064460B (zh) | 一种mmlv突变体及其应用 | |
CN108841919B (zh) | 一种嵌合式sda法制备探针 | |
WO2023116376A1 (zh) | 单细胞核酸标记和分析方法 | |
US20230287396A1 (en) | Methods and compositions of nucleic acid enrichment | |
KR20230104207A (ko) | 헤어핀 올리고뉴클레오티드 및 그의 용도 | |
CN118207310A (zh) | 一种可剪切环状引物及其试剂盒与扩增方法 | |
AU2003254445B2 (en) | Nucleic acid amplification method | |
CN118127136A (zh) | 减少多重pcr法检测中引物二聚体形成的方法 | |
CN116656760A (zh) | 用于加A法miRNA合成第一链cDNA的方法及产品 | |
CN118302538A (zh) | 一种用于检测剪接异构体的靶向高通量测序方法 | |
WO2022256228A1 (en) | Method for producing a population of symmetrically barcoded transposomes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240313 Address after: 210034 East Section 4, Building C2, Hongfeng Science and Technology Park, No.1 Zhixin Road, Nanjing Economic and Technological Development Zone, Jiangsu Province Patentee after: Nanjing nuoweizan animal health Co.,Ltd. Country or region after: China Address before: 210046 floors 1-6, east section, building C1-2, Hongfeng Science Park, Kechuang Road, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu Province Patentee before: Nanjing novozan Biotechnology Co.,Ltd. Country or region before: China |